HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Passive immunisation of hamsters against Clostridium difficile infection using antibodies to surface layer proteins.

Abstract
Clostridium difficile is a major cause of antibiotic-associated diarrhoea and the primary cause of pseudomembraneous colitis in hospitalised patients. We assessed the protective effect of anti-surface layer protein (SLP) antibodies on C. difficile infection in a lethal hamster challenge model. Post-challenge survival was significantly prolonged in the anti-SLP treated group compared with control groups (P=0.0281 and P=0.0283). The potential mechanism of action of the antiserum was shown to be through enhancement of C. difficile phagocytosis. This report indicates that anti-SLP antibodies can modulate the course of C. difficile infection and may therefore merit closer investigation for use as constituents of multi-component vaccines against C. difficile associated diarrhoea.
AuthorsJulie B O'Brien, Matthew S McCabe, Verónica Athié-Morales, George S A McDonald, Déirdre B Ní Eidhin, Dermot P Kelleher
JournalFEMS microbiology letters (FEMS Microbiol Lett) Vol. 246 Issue 2 Pg. 199-205 (May 15 2005) ISSN: 0378-1097 [Print] England
PMID15899406 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Bacterial
  • Bacterial Proteins
  • Membrane Glycoproteins
  • S-layer proteins
Topics
  • Animals
  • Antibodies, Bacterial (immunology, therapeutic use)
  • Bacterial Proteins (immunology)
  • Cell Line
  • Clostridioides difficile (immunology)
  • Cricetinae
  • Disease Models, Animal
  • Enterocolitis, Pseudomembranous (prevention & control)
  • Female
  • Humans
  • Immunization, Passive
  • Membrane Glycoproteins (immunology)
  • Mesocricetus
  • Monocytes
  • Phagocytosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: